Safety and Efficacy of Camrelizumab in Combination With Nab-Paclitaxel Plus S-1 for the Treatment of Gastric Cancer With Serosal Invasion

ObjectiveTo investigate the safety and efficacy of camrelizumab in combination with nab-paclitaxel plus S-1 for the treatment of gastric cancer with serosal invasion.MethodTwo hundred patients with gastric cancer with serosal invasion who received neoadjuvant therapy from January 2012 to December 20...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Ju-Li Lin, Jian-Xian Lin, Jun Peng Lin, Chao-Hui Zheng, Ping Li, Jian-Wei Xie, Jia-bin Wang, Jun Lu, Qi-Yue Chen, Chang-Ming Huang
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2022-01-01
Saila:	Frontiers in Immunology
Gaiak:	gastric cancer camrelizumab (SHR-1210) neoadjuvant chemotherapy tumor regression rate pCR
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.783243/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!